A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME)
Public ClinicalTrials.gov record NCT04469595. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Masked, Controlled Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME)
Study identification
- NCT ID
- NCT04469595
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Alimera Sciences
- Industry
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Interventions
- Aflibercept Drug
- Iluvien 0.19 MG Drug Implant Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 30, 2020
- Primary completion
- Dec 30, 2024
- Completion
- Dec 30, 2024
- Last update posted
- Jul 30, 2024
2020 – 2024
United States locations
- U.S. sites
- 40
- U.S. states
- 18
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigative Site | Phoenix | Arizona | 85020 | — |
| Investigative Site | Tucson | Arizona | 85704 | — |
| Investigative Site | Beverly Hills | California | 90211 | — |
| Investigative Site | Glendale | California | 91203 | — |
| Investigative Site | Laguna Hills | California | 92653 | — |
| Investigative Site | Santa Ana | California | 92705 | — |
| Investigative Site | Colorado Springs | Colorado | 80909 | — |
| Investigative Site | Clearwater | Florida | 33761 | — |
| Investigative Site | Orlando | Florida | 32806 | — |
| Investigative Site | Palm Beach Gardens | Florida | 33418 | — |
| Investigative Site | Tampa | Florida | 33609 | — |
| Investigative Site | Marietta | Georgia | 30060 | — |
| Investigative Site | Sandy Springs | Georgia | 30328 | — |
| Investigative Site | Elmhurst | Illinois | 60126 | — |
| Investigative Site | Lemont | Illinois | 60439 | — |
| Investigative Site | Oak Park | Illinois | 60304 | — |
| Investigative Site | Springfield | Illinois | 62704 | — |
| Investigative Site | Leawood | Kansas | 66211 | — |
| Investigative Site | Shawnee Mission | Kansas | 66204 | — |
| Investigative Site | West Monroe | Louisiana | 71291 | — |
| Investigative Site | Baltimore | Maryland | 21237 | — |
| Investigative Site | Detroit | Michigan | 48201 | — |
| Investigative Site | Grand Blanc | Michigan | 48439 | — |
| Investigative Site | Independence | Missouri | 64055 | — |
| Investigative Site | Bloomfield | New Jersey | 07003 | — |
| Investigative Site | Beachwood | Ohio | 44122 | — |
| Investigative Site | Cincinnati | Ohio | 45242 | — |
| Investigative Site | Cleveland | Ohio | 22106 | — |
| Investigative Site | Youngstown | Ohio | 44505 | — |
| Investigative Site | Tulsa | Oklahoma | 74114 | — |
| Investigative Site | Erie | Pennsylvania | 16507 | — |
| Investigative Site | Columbia | South Carolina | 29169 | — |
| Investigative Site | Dallas | Texas | 75231 | — |
| Investigative Site | Houston | Texas | 77030 | — |
| Investigative Site | McAllen | Texas | 78503 | — |
| Investigative Site | San Antonio | Texas | 72815 | — |
| Investigative Site | San Antonio | Texas | 78240 | — |
| Investigative Site | The Woodlands | Texas | 77384 | — |
| Investigative Site | Roanoke | Virginia | 24018 | — |
| Investigative Site | Warrenton | Virginia | 20186 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04469595, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 30, 2024 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04469595 live on ClinicalTrials.gov.